Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4474898
Max Phase: Preclinical
Molecular Formula: C19H25N3S
Molecular Weight: 327.50
Molecule Type: Unknown
Associated Items:
ID: ALA4474898
Max Phase: Preclinical
Molecular Formula: C19H25N3S
Molecular Weight: 327.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1(C)[C@@H]2CC[C@@]1(C)/C(=N/CCSc1nc3ccccc3[nH]1)C2
Standard InChI: InChI=1S/C19H25N3S/c1-18(2)13-8-9-19(18,3)16(12-13)20-10-11-23-17-21-14-6-4-5-7-15(14)22-17/h4-7,13H,8-12H2,1-3H3,(H,21,22)/b20-16+/t13-,19+/m1/s1
Standard InChI Key: NTUHFSKVZJRWCE-GBLRRJHTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 327.50 | Molecular Weight (Monoisotopic): 327.1769 | AlogP: 4.94 | #Rotatable Bonds: 4 |
Polar Surface Area: 41.04 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.46 | CX Basic pKa: 6.84 | CX LogP: 4.93 | CX LogD: 4.82 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: -0.39 |
1. Yarovaya OI, Sokolova AS, Mainagashev IY, Volobueva AS, Lantseva K, Borisevich SS, Shtro AA, Zarubaev VV, Salakhutdinov NF.. (2019) Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents., 29 (23): [PMID:31668423] [10.1016/j.bmcl.2019.126745] |
Source(1):